Fig. 1 · Structure

Documents & Downloads

Tectoridin

Cat. No. A12129 CAS 611-40-5
Tectoridin, an isoflavone glycoside from the flower of Pueraria lobata, prevents acute ethanol-induced liver steatosis in mice.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Tectoridin Research Summary

This section summarizes 2 in vitro studies and 1 in vivo study of Tectoridin from 3 published references. In vitro models include R. solani strain YWK196.

Tectoridin In Vitro Studies

Tectoridin had a relatively weak effect on R. solani growth, reducing growth by 12.4% at concentrations up to 300 μm. In isolated anagen vibrissae hair follicles from male mice, Tectoridin treatment at 50 µM or 100 µM for 3 days produced hair growth exceeding 60%. [1,2]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Fungal Colony Growth Response

Cell-based study · R. solani strain YWK196 [1]

In R. solani strain YWK196, Tectoridin applied on medium at concentrations up to 300 μm had a relatively weak effect, reducing growth by 12.4%.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
diameter of the colonygrowth reducing R. solani growth by 12.4%[1]

Literature-Reported Treatment Conditions

Treatment concentration
up to 300 μm
Exposure duration
48 h
Method
on medium containing DMSO, tectorigenin, or tectoridin
Vehicle
DMSO
Methods and source locations

Compound reported in the paper: Tectoridin

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Results > Tectorigenin and tectoridin provide biotic resistance against plant pathogens in vitro and in vivo (S13, S15); Materials and methods > The antibacterial and antifungal effects of the compounds in vitro and in vivo (S136); Figure 1 legend (S223, S225)

diameter of the colony: diameter of the colony; comparator: DMSO — Results > Tectorigenin and tectoridin provide biotic resistance against plant pathogens in vitro and in vivo (S15); Materials and methods > The antibacterial and antifungal effects of the compounds in vitro and in vivo (S136)

Hair growth in isolated anagen vibrissae follicles

Cell-based study · Individual anagen vibrissae hair follicles were isolated from the upper lip pad of 4-week-old C57BL/6 male mice [2]

Isolated anagen vibrissae hair follicles from male mice were treated with Tectoridin at 50 µM or 100 µM for 3 days. Hair growth exceeded 60%.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Hair shaft elongation was measured from bottom of hair follicle to the epidermishair length over 60%[2]

Literature-Reported Treatment Conditions

Treatment concentration
50 µM or 100 µM
Exposure duration
3 days
Method
the isolated vibrissae hair follicles were treated
Vehicle
DMSO
Methods and source locations

Compound reported in the paper: Tectoridin

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

2. Results > 2.2. Tectoridin Induces Hair Growth (S42, S44); 4. Materials and Methods > 4.1. Materials (S48); Figure 4 legend (S123, S125, S127)

Hair shaft elongation was measured from bottom of hair follicle to the epidermis: Hair shaft elongation was measured from bottom of hair follicle to the epidermis; comparator: control group was treated with 0.02% DMSO — 2. Results > 2.2. Tectoridin Induces Hair Growth (S44); Figure 4 legend (S125)

Tectoridin In Vivo Studies

Tectoridin was evaluated in ICR male rats with I/R involving middle cerebral artery occlusion. Treatment relieved neurological severity indicators compared with the I/R cohort. [3]

Neurological severity in rats with I/R

Animal study · ICR male rats; I/R [3]

In ICR male rats with I/R, Tectoridin treatment relieved neurological severity indicators compared with the I/R cohort.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Longa’s neurological severity scale; one day after the sham or I/R surgeryReported result The mentioned indicators received the remarkable relieving process inside the tectoridin cohort at 5, 10, and 20 mg/kg (p < 0.05, p < 0.05, p < 0.01).[3]

Conditions shared by the study groups

Route
intragastric administration; intraperitoneally injected
Treatment course
once per day; 2 weeks of pre-surgery treatment; 10 min after the ischemia
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
Tectoridin 5, 10, and 20 mg/kgI/R cohortThe mentioned indicators received the remarkable relieving process inside the tectoridin cohort at 5, 10, and 20 mg/kg (p < 0.05, p < 0.05, p < 0.01).[3]
Tectoridin 5, 10, and 20 mg/kg
Model: ICR male rats; I/R
Reported limits: Not stated in the sentences used: vehicle.
Methods and source locations

Compound reported in the paper: Tectoridin

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

2. Results > 2.2. Tectoridin Down-Regulated Rats’ Neurological Impairment Scores and Infarct Volume After I/R (S21, S22); 4. Materials and Methods > 4.2. Experimental Verification > 4.2.3. Animals and Treatment (S70, S72, S73, S75, S76); 4. Materials and Methods > 4.2. Experimental Verification > 4.2.4. Neurological Deficit Evaluation (S81); Figure 4 legend (S114)

Longa’s neurological severity scale; one day after the sham or I/R surgery: Longa’s neurological severity scale; one day after the sham or I/R surgery; comparator: I/R cohort — 2. Results > 2.2. Tectoridin Down-Regulated Rats’ Neurological Impairment Scores and Infarct Volume After I/R (S22); 4. Materials and Methods > 4.2. Experimental Verification > 4.2.4. Neurological Deficit Evaluation (S81)

Tectoridin 5, 10, and 20 mg/kg · 2. Results > 2.2. Tectoridin Down-Regulated Rats’ Neurological Impairment Scores and Infarct Volume After I/R (S22); 4. Materials and Methods > 4.2. Experimental Verification > 4.2.3. Animals and Treatment (S72, S73, S76)

Specifications

Manufacturer Adooq Bioscience
CAS Number 611-40-5
Formula C22H22O11
Molecular Weight 462.4
Synonyms Tectorigenin 7-glucoside; Glycosylated tectorigenin; Shekanin
SMILES
COC1=C(C=C2C(=C1O)C(=O)C(=CO2)C3=CC=C(C=C3)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Tectoridin Research References

  1. [1] Cheng W, Fang X, Guan Z, et al. Functional characterization and structural basis of a reversible glycosyltransferase involves in plant chemical defence. Plant Biotechnol J (2023). PMID: 37581303 DOI: 10.1111/pbi.14157 Source material
  2. [2] Yuen GK, Ho BS, Lin LS, et al. Tectoridin Stimulates the Activity of Human Dermal Papilla Cells and Promotes Hair Shaft Elongation in Mouse Vibrissae Hair Follicle Culture. Molecules (2022). PMID: 35056713 DOI: 10.3390/molecules27020400 Source material
  3. [3] Lu T, Feng Z, Xue H, et al. Network Pharmacology Analysis and Experimental Validation of Tectoridin in the Treatment of Ischemic Stroke by Inhibiting Apoptosis and Regulating Inflammation. Int J Mol Sci (2025). PMID: 40003867 DOI: 10.3390/ijms26041402 Source material

Added to your cart

View Cart Checkout
Loading...